A contemporary assessment of nocturia: Definition, epidemiology, pathophysiology, and management - A systematic review and meta-analysis

European Urology

Volumn 62, Issue 5, 2012, Pages 877-890

  Cornu, Jean Nicolas ^a   Abrams, Paul ^b   Chapple, Christopher R ^c   Dmochowski, Roger R ^d   Lemack, Gary E ^e   Michel, Martin C ^f   Tubaro, Andrea ^g   Madersbacher, Stephan ^h  

^a HÔPITAL TENON   (France)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h Donauspital ^*  (Austria)

Author keywords

1 Blockers; Antimuscarinics; Desmopressin; Meta analysis; Nocturia; Nocturnal polyuria; Systematic review

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CELECOXIB; DESMOPRESSIN; DICLOFENAC; DOXAZOSIN; FINASTERIDE; FUROSEMIDE; MELATONIN; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; TAMSULOSIN; TOLTERODINE;

ABDOMINAL PAIN; ALGORITHM; BEDTIME DOSAGE; BLADDER CAPACITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DATA BASE; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG INDUCED HEADACHE; EMBASE; EXERCISE; GENDER; HUMAN; HYPERTENSION; HYPONATREMIA; INSOMNIA; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LOWER URINARY TRACT SYMPTOM; META ANALYSIS; MORBIDITY; NAUSEA; NOCTURIA; NOCTURNAL POLYURIA; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PLANT PRODUCT; POLYURIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SYSTEMATIC REVIEW; XEROSTOMIA;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; ANTI-INFLAMMATORY AGENTS; ANTIDIURETIC AGENTS; CHI-SQUARE DISTRIBUTION; DIAGNOSTIC TECHNIQUES, UROLOGICAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NOCTURIA; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME; URODYNAMICS; UROLOGIC SURGICAL PROCEDURES;

EID: 84867048874     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.07.004     Document Type: Review

References (97)

1. J.L. Bosch, and J.P. Weiss The prevalence and causes of nocturia J Urol 184 2010 440 446
2. P. van Kerrebroeck, P. Abrams, and D. Chaikin The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 179 183
3. D.E. Irwin, I. Milsom, and S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306 1315
4. L. van Dijk, D.G. Kooij, F.G. Schellevis, A.A. Kaptein, T.A. Boon, and M. Wooning Nocturia: impact on quality of life in a Dutch adult population BJU Int 93 2004 1001 1004
5. F.Y. Chen, Y.T. Dai, C.K. Liu, H.J. Yu, C.Y. Liu, and T.H. Chen Perception of nocturia and medical consulting behavior among community-dwelling women Int Urogynecol J Pelvic Floor Dysfunct 18 2007 431 436
6. P.E. Van Kerrebroeck, R. Dmochowski, and M.P. FitzGerald Nocturia research: current status and future perspectives Neurourol Urodyn 29 2010 623 628
7. J.P. Weiss, J.G. Blaivas, and D.L. Bliwise The evaluation and treatment of nocturia: a consensus statement BJU Int 108 2011 6 21
8. C.R. Chapple, J.E. Batista, and R. Berges The impact of nocturia in patients with LUTS/BPH: need for new recommendations Eur Urol Suppl 5 2006 12 18
9. P. Abrams New words for old: lower urinary tract symptoms for "prostatism." BMJ 308 1994 929 930
10. C.R. Chapple Lower urinary tract symptoms revisited Eur Urol 56 2009 21 23
11. J.P. Weiss, A.J. Wein, and P. van Kerrebroeck Nocturia: new directions Neurourol Urodyn 30 2011 700 703
12. J.P. Weiss, A.C. Weinberg, and J.G. Blaivas New aspects of the classification of nocturia Curr Urol Rep 9 2008 362 367
13. K.S. Coyne, Z. Zhou, S.K. Bhattacharyya, C.L. Thompson, R. Dhawan, and E. Versi The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA BJU Int 92 2003 948 954
14. K.A.O. Tikkinen, T.M. Johnson II, and T.L.J. Tammela Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland Eur Urol 57 2010 488 498
15. Y. Endeshaw Correlates of self-reported nocturia among community-dwelling older adults J Gerontol A Biol Sci Med Sci 64 2009 142 148
16. M.H. Bing, L.A. Moller, P. Jennum, S. Mortensen, and G. Lose Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population Eur Urol 49 2006 710 719
17. D.M. Gulur, A.M. Mevcha, and M.J. Drake Nocturia as a manifestation of systemic disease BJU Int 107 2011 702 713
18. J.P. Weiss Nocturia: "do the math." J Urol 175 2006 S16 S18
19. J.P. Weiss, J.L. Bosch, and M. Drake Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011 Neurourol Urodyn 31 2012 330 339
20. J.P. Weiss, P.E. van Kerrebroeck, B.M. Klein, and J.P. Norgaard Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia J Urol 186 2011 1358 1363
21. T. Schneider, J.J. de la Rosette, and M.C. Michel Nocturia: a non-specific but important symptom of urological disease Int J Urol 16 2009 249 256
22. Y. Udo, M. Nakao, H. Honjo, O. Ukimura, H. Kitakoji, and T. Miki Sleep duration is an independent factor in nocturia: analysis of bladder diaries BJU Int 104 2009 75 79
23. J.T. Hakkinen, R. Shiri, J. Koskimaki, T.L. Tammela, A. Auvinen, and M. Hakama Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS) J Urol 179 2008 1897 1901
24. R. Asplund, S. Henriksson, S. Johansson, and G. Isacsson Nocturia and depression BJU Int 93 2004 1253 1256
25. K. Yoshimura Correlates for nocturia: a review of epidemiological studies Int J Urol 19 2012 317 329
26. J.T. Hakkinen, M. Hakama, R. Shiri, A. Auvinen, T.L. Tammela, and J. Koskimaki Incidence of nocturia in 50 to 80-year-old Finnish men J Urol 176 2006 2541 2545
27. M.P. Fitzgerald, H.J. Litman, C.L. Link, and J.B. McKinlay The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey J Urol 177 2007 1385 1389
28. K.L. Burgio, T.M. Johnson II, and P.S. Goode Prevalence and correlates of nocturia in community-dwelling older adults J Am Geriatr Soc 58 2010 861 866
29. K. Yoshimura, T. Kamoto, T. Tsukamoto, K. Oshiro, N. Kinukawa, and O. Ogawa Seasonal alterations in nocturia and other storage symptoms in three Japanese communities Urology 69 2007 864 870
30. C.H. Liao, H.S. Chiang, and H.J. Yu Serum testosterone levels significantly correlate with nocturia in men aged 40-79 years Urology 78 2011 631 635
31. P.M. McKeigue, and J.M. Reynard Relation of nocturnal polyuria of the elderly to essential hypertension Lancet 355 2000 486 488
32. C.P. Vaughan, T.M. Johnson II, P.S. Goode, D.T. Redden, K.L. Burgio, and A.D. Markland Vitamin D and lower urinary tract symptoms among US men: results from the 2005-2006 National Health and Nutrition Examination Survey Urology 78 2011 1292 1297
33. K.A. Tikkinen, A. Auvinen, A. Tiitinen, A. Valpas, T.M. Johnson II, and T.L. Tammela Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland Am J Obstet Gynecol 199 2008 153 e1-12
34. Z. Lu, Y. Gao, and A. Tan Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang area male health and examination survey Prostate 72 2012 193 200
35. V. Kupelian, K.T. McVary, and S.A. Kaplan Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey J Urol 182 2009 616 624
36. A.L. Wennberg, D. Altman, and C. Lundholm Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins Eur Urol 59 2011 1032 1038
37. H.C. Klingler, H. Heidler, H. Madersbacher, and G. Primus Nocturia: an Austrian study on the multifactorial etiology of this symptom Neurourol Urodyn 28 2009 427 431
38. V. Kupelian, J.T. Wei, M.P. O'Leary, J.P. Norgaard, R.C. Rosen, and J.B. McKinlay Nocturia and quality of life: results from the Boston Area Community Health Survey Eur Urol 61 2012 78 84
39. D.L. Bliwise, D.J. Foley, M.V. Vitiello, F.P. Ansari, S. Ancoli-Israel, and J.K. Walsh Nocturia and disturbed sleep in the elderly Sleep Med 10 2009 540 548
40. E. Chartier-Kastler, and C.R. Chapple LUTS/BPH in clinical practice: the importance of nocturia and quality of sleep BJU Int 98 2006 3 8
41. R. Asplund Nocturia: consequences for sleep and daytime activities and associated risks Eur Urol Suppl 3 2005 24 32
42. K. Yoshimura, Y. Oka, and T. Kamoto Night-time frequency, sleep disturbance and general health-related quality of life: is there a relation? Int J Urol 16 2009 96 100
43. J.J. Wyndaele Nocturia and quality of life Eur Urol 61 2012 85 87
44. R. Asplund Hip fractures, nocturia, and nocturnal polyuria in the elderly Arch Gerontol Geriatr 43 2006 319 326
45. J.K. Parsons, J. Mougey, and L. Lambert Lower urinary tract symptoms increase the risk of falls in older men BJU Int 104 2009 63 68
46. C. Temml, A. Ponholzer, G. Gutjahr, I. Berger, M. Marszalek, and S. Madersbacher Nocturia is an age-independent risk factor for hip-fractures in men Neurourol Urodyn 28 2009 949 952
47. H. Nakagawa, K. Niu, and A. Hozawa Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study J Urol 184 2010 1413 1418
48. Lightner DJ, Krambeck AE, Jacobson DJ, et al. Nocturia is associated with an increased risk of coronary heart disease and death. BJU Int. In press. http://dx.doi.org/10.1111/j.1464-410X.2011.10806.x.
49. M. Bursztyn, J. Jacob, and J. Stessman Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921 Am J Cardiol 98 2006 1311 1315
50. V. Kupelian, M.P. Fitzgerald, S.A. Kaplan, J.P. Norgaard, G.R. Chiu, and R.C. Rosen Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey J Urol 185 2011 571 577
51. B. van Doorn, E.T. Kok, M.H. Blanker, P. Westers, and J.L. Bosch Mortality in older men with nocturia: a 15-year followup of the Krimpen study J Urol 187 2012 1727 1731
52. T.L. Yap, D.A. Cromwell, C. Brown, J. van der Meulen, and M. Emberton The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms Eur Urol 52 2007 811 818
53. L. Abraham, A. Hareendran, and I.W. Mills Development and validation of a quality-of-life measure for men with nocturia Urology 63 2004 481 486
54. E. Chartier-Kastler, and K. Davidson Evaluation of quality of life and quality of sleep in clinical practice Eur Urol Suppl 6 2007 576 584
55. S.O. Kim, H.S. Choi, and Y.J. Kim Impact of nocturia on health-related quality of life and Medical Outcomes Study sleep score in men Int Neurourol J 15 2011 82 86
56. S. Kim, D. Kwon, and E.C. Hwang The effect of nocturia on health-related quality of life and MOS sleep score in female Neurourol Urodyn 28 2009 927 928
57. P. van Kerrebroeck, H. Hashim, T. Holm-Larsen, D. Robinson, and N. Stanley Thinking beyond the bladder: antidiuretic treatment of nocturia Int J Clin Pract 64 2010 807 816
58. T.M. Johnson II, K.L. Burgio, D.T. Redden, K.C. Wright, and P.S. Goode Effects of behavioral and drug therapy on nocturia in older incontinent women J Am Geriatr Soc 53 2005 846 850
59. J.M. Reynard, A. Cannon, Q. Yang, and P. Abrams A novel therapy for nocturnal polyuria: a double-blind randomized trial of furosemide against placebo Br J Urol 81 1998 215 218
60. R. Macdonald, J.W. Tacklind, I. Rutks, and T.J. Wilt Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review BJU Int 109 2012 1756 1761
61. T. Wilt, A. Ishani, R. Mac Donald, I. Rutks, and G. Stark Pygeum africanum for benign prostatic hyperplasia Cochrane Database Syst Rev 2002 CD001044
62. K. Zhang, W. Yu, and J. Jin Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study Urology 78 2011 636 640
63. V. Simaioforidis, A.G. Papatsoris, M. Chrisofos, M. Chrisafis, S. Koritsiadis, and C. Deliveliotis Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia Int J Urol 18 2011 243 248
64. B. Djavan, S. Milani, J. Davies, and J. Bolodeoku The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study Eur Urol Suppl 4 2005 61 68
65. T.M. Johnson II, P.K. Burrows, and J.W. Kusek The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia J Urol 178 2007 2045 2050
66. T.M. Johnson II, K. Jones, W.O. Williford, M.H. Kutner, M.M. Issa, and H. Lepor Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial J Urol 170 2003 145 148
67. R. Rackley, J.P. Weiss, E.S. Rovner, J.T. Wang, and Z. Guan Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia Urology 67 2006 731 736
68. C.R. Chapple, L. Cardozo, W.D. Steers, and F.E. Govier Solifenacin significantly improves all symptoms of overactive bladder syndrome Int J Clin Pract 60 2006 959 966
69. O. Yokoyama, O. Yamaguchi, and H. Kakizaki Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary J Urol 186 2011 170 174
70. M.P. Fitzgerald, G. Lemack, T. Wheeler, and H.J. Litman Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy Int Urogynecol J Pelvic Floor Dysfunct 19 2008 1545 1550
71. C.R. Chapple, V. Khullar, Z. Gabriel, D. Muston, C.E. Bitoun, and D. Weinstein The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis Eur Urol 54 2008 543 562
72. J.P. Weiss, J.G. Blaivas, M. Jones, J.T. Wang, and Z. Guan Age related pathogenesis of nocturia in patients with overactive bladder J Urol 178 2007 548 551 discussion 551
73. S. Falahatkar, G. Mokhtari, F. Pourreza, S.A. Asgari, and A.N. Kamran Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study Urology 72 2008 813 816
74. S.K. Addla, A.B. Adeyoju, D. Neilson, and P. O'Reilly Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study Eur Urol 49 2006 720 726
75. M.J. Drake, J.G. Noble, and I. Mills A randomised double blind crossover trial of melatonin to treat nocturia in men with benign prostatic hypertrophy J Urol 171 2004 1199 1202
76. R. Asplund, B. Sundberg, and P. Bengtsson Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study BJU Int 83 1999 591 595
77. G. Lose, O. Lalos, R.M. Freeman, and P. van Kerrebroeck Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women Am J Obstet Gynecol 189 2003 1106 1113
78. A. Mattiasson, P. Abrams, P. Van Kerrebroeck, S. Walter, and J. Weiss Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men BJU Int 89 2002 855 862
79. B. Rezakhaniha, N. Arianpour, and S. Siroosbakhat Efficacy of desmopressin in treatment of nocturia in elderly men J Res Med Sci 16 2011 516 523
80. P. van Kerrebroeck, M. Rezapour, A. Cortesse, J. Thüroff, A. Riis, and J.P. Norgaard Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study Eur Urol 52 2007 221 229
81. A. Cannon, P.G. Carter, A.A. McConnell, and P. Abrams Desmopressin in the treatment of nocturnal polyuria in the male BJU Int 84 1999 20 24
82. G.M. Hvistendahl, A. Riis, J.P. Norgaard, and J.C. Djurhuus The pharmacokinetics of 400 μg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect BJU Int 95 2005 804 809
83. T.M. Johnson, A. Burridge, M.M. Issa, M. Miller, T. Tang, and J.G. Ouslander The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study J Am Geriatr Soc 55 2007 562 569
84. C.J. Wang, Y.N. Lin, S.W. Huang, and C.H. Chang Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study J Urol 185 2011 219 223
85. F.G. Fu, H.J. Lavery, and D.L. Wu Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin Neurourol Urodyn 30 2011 312 316
86. S.D. Eckford, K.S. Swami, S.R. Jackson, and P.H. Abrams Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis Br J Urol 74 1994 733 735
87. S. Fredrikson Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis Acta Neurol Scand 94 1996 31 34
88. G. Valiquette, J. Herbert, and P. Maede-D'Alisera Desmopressin in the management of nocturia in patients with multiple sclerosis: a double-blind, crossover trial Arch Neurol 53 1996 1270 1275
89. P.A. Hoverd, and C.J. Fowler Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis J Neurol Neurosurg Psychiatry 65 1998 778 780
90. J.P. Weiss, N.R. Zinner, B.M. Klein, and J.P. Norgaard Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial Neurourol Urodyn 31 2012 441 447
91. P. Hilton, K. Hertogs, and S.L. Stanton The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis J Neurol Neurosurg Psychiatry 46 1983 854 855
92. A.C. Kinn, and P.O. Larsson Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis Scand J Urol Nephrol 24 1990 109 112
93. P. Hilton, and S.L. Stanton The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female Br J Urol 54 1982 252 255
94. H. Zong, C. Yang, X. Peng, and Y. Zhang Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials Int Urol Nephrol 44 2012 377 384
95. G. Lose, A. Mattiasson, and S. Walter Clinical experiences with desmopressin for long-term treatment of nocturia J Urol 172 2004 1021 1025
96. G.M. Hvistendahl, J. Frokiaer, S. Nielsen, and J.C. Djurhuus Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin J Urol 178 2007 2671 2676
97. National Institute for Health and Clinical Excellence. NICE Clinical Guidelines. Lower urinary tract symptoms: the management of lower urinary tract symptoms in men. http://publications.nice.org.uk/lower-urinary-tract-symptoms- cg97. Accessed June 4, 2012.